Promising in vitro pre-clinical studi...

Promising in vitro pre-clinical studies in non-Hodgkin's lymphoma

Posted in the Lymphoma Forum


Madison, WI

#1 Aug 11, 2011
In a study reported online in the journal Leukemia, researchers from Mayo Clinic have shown that gamma-secretase inhibitor (MRK003) exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma. This study has evaluated MRK003 in combination with Akt1/2 kinase inhibitor and observed synergy in killing multiple myeloma and non-Hodgkin's lymphoma cell lines examined. Details:

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Lymphoma Discussions

Title Updated Last By Comments
News Helping ease cancer battle (Feb '09) Nov 1 martin garey 8
News Can the Sunshine Vitamin Help Lymphoma Patients? Jul '17 duh 1
News Support umbilical cord blood banking (Apr '09) Jun '17 Anonymous 7
News Columnist, MSU spokesman Salter diagnosed with ... (May '17) May '17 Paperboy 1
News Seattle Genetics Demonstrates Commitment to Imp... (Oct '16) Oct '16 Rockstar 2
pharmacist - viagra can cause blue, blurry vision (Apr '16) Apr '16 Huff 1
tadalafil (cialis) in the treatment of erectile... (Mar '16) Mar '16 Becker 1
More from around the web